Navigation Links
Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty
Date:3/9/2011

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) have announced that Professor Gerard Karsenty of the Columbia University Medical Center is to be awarded the first Herbert A. Fleisch ESCEO-IOF Medal. Herbert Fleisch was a renowned researcher whose groundbreaking work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment.

The newly created award, valued at 20,000 Euro, recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science. The Medal will be presented on March 23rd at an award ceremony to take place at the opening of the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF), in Valencia, Spain.

Gerard Karsenty M.D., Ph.D., is Professor and Chair, Department of Genetics & Development, at the Columbia University Medical Center, New York. Professor Karsenty is renowned for his many fundamental contributions to understanding skeletal development and skeletal physiology. His laboratory has been instrumental in identifying Runx2 as the master gene of osteoblast differentiation and in deciphering the entire genetic cascade of osteoblast differentiation. He has contributed to the molecular elucidation of bone mineralization and has made significant advances in the study of bone physiology, based on the hypothesis he proposed that there must be a common control of bone mass, energy metabolism and reproduction. Testing this hypothesis revealed the existence of a central control of bone mass, a function regulated by leptin, a hormone appearing during evolution with bone cells and that inhibits both appetite and bone mass accrual. His laboratory then showed that bone is itself an endocrine organ producing an hormone, osteocalcin, that favors glucose homeostasis and male reproduction. Lastly Dr. Karsentys lab has shown that gut-derived serotonin is a powerful inhibitor of bone formation.

"Gerard Karsenty has been one of the most creative minds in the bone field, making exciting new findings that have furthered our understanding of skeletal physiology and the mechanisms of bone formation, said Professor Jean-Yves Reginster, President of ESCEO.

IOF President John Kanis went on to state, "This award, named in honour of a pioneer in osteoporosis research, appropriately recognizes an individual whose work has considerably influenced knowledge about bone and mineral metabolism."

Professor Karsenty has received a number of honours and awards, including the Lee C. Howley Prize for Arthritis Research in 2008. He is the Chair of the upcoming 1st IOF-ESCEO Pre-Clinical Symposium, to be held in Valencia from March 22-23, 2011.


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. International AIDS Society announces inaugural recipients of innovative HIV research awards
2. George Whitesides accepts inaugural Dreyfus Prize in the Chemical Sciences
3. George M. Whitesides receives inaugural Dreyfus prize in the chemical sciences
4. Easton honored with inaugural AACR Outstanding Investigator Award in Breast Cancer Research
5. Massague honored with inaugural AACR Distinguished Leadership Award in Breast Cancer Research
6. Penn presents inaugural symposium on applied mathematics and computational science
7. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
8. Nobel laureate claims the 2010 Herbert Tabor Lectureship
9. ESCEO-IOF-ABBH Young Investigator Awards recognize research excellence
10. Genetic studies of human evolution win researcher 2011 Gani Medal
11. NIMHs Dr. Mortimer Mishkin to be awarded National Medal of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... ... August 16, 2017 , ... ... Food and Drug Administration (FDA) inspection at our Dilworth, MN site. The inspection ... issued. This inspection was conducted as part of a routine Bioresearch Monitoring Program ...
(Date:8/15/2017)... After spending the past two years building a state-of-the-art technology which ... offers this platform to healthcare stakeholders (hospitals, foundations, biopharma companies etc.) ... collection vis a vis their members, under their own brand. Three ... offer. ... ...
(Date:8/15/2017)... ... August 15, 2017 , ... Pittcon is ... for analytical and scientific instruments. This year’s symposium, organized by the Pittcon 2018 ... Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ionization processes, high ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... 360° (IO360°) programming through a series of upcoming panels and events. The partnership culminates ... at The Roosevelt Hotel in New York City. , “With our experience in producing ...
Breaking Biology Technology: